Endocrine oncology

Machine Learning: A Multicenter Study on Predicting Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma

J Clin Endocrinol MetabPublished Diagnostic accuracy study

Authors' conclusion

ML, especially RF, reliably predicts lateral LNM in cN0 PTC patients, outperforming traditional nomograms.

Study context

Population
cN0 papillary thyroid carcinoma (PTC) patients diagnosed via fine-needle aspiration biopsy; training/testing sets from hospital A (7:3), validation set from hospital B1,616 hospital A + 243 validation
Comparison
Machine learning models vs traditional nomograms for predicting lateral lymph node metastasis (LNM)
Outcome
Prediction of ipsilateral lateral and level II, III and IV LNM
Methodological detailsmulticenter, machine learning, external validation set, 10-fold cross-validation, Web-based calculator for each of the 4 dependent variables
  • Multicenter
  • Machine learning
  • External validation set
  • 10-fold cross-validation
  • Web-based calculator for each of the 4 dependent variables

Performance

As reported in the abstract

Ipsilateral lateral LNM
Test or modelAccuracy (testing/validation)AUC (testing/validation)Specificity (testing/validation)Sensitivity (testing/validation)
Random forest (RF)0.773/0.7280.858/0.7990.984/0.9350.757/0.807

Random forest (RF)

Accuracy (testing/validation)0.773/0.728
AUC (testing/validation)0.858/0.799
Specificity (testing/validation)0.984/0.935
Sensitivity (testing/validation)0.757/0.807

Further findings

Level II, III and IV LNM

Similar results for the other dependent variables, RF models relying on distinct but overlapping feature sets

Original publication

Machine Learning: A Multicenter Study on Predicting Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. Published 8 February 2025. doi:10.1210/clinem/dgaf070

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.